Sotera Health Announces First-Quarter 2025 Earnings Release Date
Sotera Health (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its first-quarter 2025 financial results release for Thursday, May 1, 2025, before market opening.
The company will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss Q1 2025 results and operating highlights. Participants can join via phone (1-844-481-2916 US toll-free; 1-412-317-0709 international) or access the live webcast through the Investor Relations section of Sotera Health's website. Conference materials will be available, and a webcast replay will be accessible later that day.
Sotera Health (Nasdaq: SHC), un fornitore globale leader di soluzioni per la sterilizzazione e servizi di laboratorio per l'industria sanitaria, ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per il giovedì 1 maggio 2025, prima dell'apertura dei mercati.
L'azienda terrà una conference call alle 9:00 del mattino, ora legale orientale, per discutere i risultati e i principali dati operativi del primo trimestre 2025. I partecipanti potranno collegarsi telefonicamente (1-844-481-2916 numero verde USA; 1-412-317-0709 internazionale) oppure seguire la diretta streaming nella sezione Investor Relations del sito web di Sotera Health. I materiali della conferenza saranno disponibili e la registrazione della webcast sarà accessibile più tardi nella stessa giornata.
Sotera Health (Nasdaq: SHC), un proveedor global líder en soluciones de esterilización y servicios de laboratorio para la industria sanitaria, ha programado la publicación de sus resultados financieros del primer trimestre de 2025 para el jueves 1 de mayo de 2025, antes de la apertura del mercado.
La compañía realizará una llamada conferencia a las 9:00 a.m., hora de verano del Este, para discutir los resultados y aspectos operativos del primer trimestre de 2025. Los participantes pueden unirse por teléfono (1-844-481-2916 línea gratuita en EE. UU.; 1-412-317-0709 internacional) o acceder a la transmisión en vivo a través de la sección de Relaciones con Inversionistas en el sitio web de Sotera Health. Los materiales de la conferencia estarán disponibles y la repetición de la transmisión se podrá ver más tarde ese mismo día.
Sotera Health (나스닥: SHC)는 의료 산업을 위한 멸균 솔루션 및 실험실 검사 서비스의 글로벌 선도 업체로서, 2025년 1분기 재무 실적 발표를 2025년 5월 1일 목요일 시장 개장 전으로 예정했습니다.
회사는 동부 일광 절약 시간 기준 오전 9시에 2025년 1분기 실적 및 운영 주요 내용을 논의하기 위한 컨퍼런스 콜을 개최합니다. 참가자는 전화(미국 무료 전화 1-844-481-2916; 국제 전화 1-412-317-0709)를 통해 참여하거나 Sotera Health 웹사이트의 투자자 관계 섹션에서 라이브 웹캐스트를 시청할 수 있습니다. 컨퍼런스 자료가 제공되며, 웹캐스트 녹화본은 같은 날 나중에 다시 볼 수 있습니다.
Sotera Health (Nasdaq : SHC), un fournisseur mondial de premier plan de solutions de stérilisation et de services de tests en laboratoire pour l'industrie de la santé, a programmé la publication de ses résultats financiers du premier trimestre 2025 pour le jeudi 1er mai 2025, avant l'ouverture des marchés.
L'entreprise tiendra une conférence téléphonique à 9h00, heure avancée de l'Est, pour discuter des résultats et des points forts opérationnels du premier trimestre 2025. Les participants pourront se joindre par téléphone (1-844-481-2916 numéro vert aux États-Unis ; 1-412-317-0709 international) ou accéder au webcast en direct via la section Relations Investisseurs du site web de Sotera Health. Les documents de la conférence seront disponibles, et un replay du webcast sera accessible plus tard dans la journée.
Sotera Health (Nasdaq: SHC), ein weltweit führender Anbieter von Sterilisationslösungen und Labortestdiensten für die Gesundheitsbranche, hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 1. Mai 2025, vor Börsenöffnung, geplant.
Das Unternehmen wird um 9:00 Uhr Eastern Daylight Time eine Telefonkonferenz abhalten, um die Ergebnisse und betrieblichen Highlights des ersten Quartals 2025 zu besprechen. Teilnehmer können telefonisch teilnehmen (1-844-481-2916 US gebührenfrei; 1-412-317-0709 international) oder den Live-Webcast über den Investor-Relations-Bereich der Sotera Health Webseite verfolgen. Konferenzunterlagen werden bereitgestellt, und eine Aufzeichnung des Webcasts wird später am selben Tag verfügbar sein.
- None.
- None.
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operating highlights.
To participate in the live call, please dial 1-844-481-2916 (toll-free in the United States), or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available on the Company’s website later in the day on May 1st.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
| Contacts | |
| Jason Peterson Vice President, Investor Relations & Treasurer IR@soterahealth.com | |
| Kristin Gibbs Chief Marketing Officer, Sotera Health kgibbs@soterahealth.com | |
Source: Sotera Health Company
FAQ
When will Sotera Health (SHC) release Q1 2025 earnings?
How can investors join Sotera Health's Q1 2025 earnings call?
Where can I find Sotera Health's (SHC) Q1 2025 earnings presentation materials?
Will there be a replay available for Sotera Health's Q1 2025 earnings call?
